Table of Content

Table of Contents



Global Radiopharmaceuticals in Nuclear Medicine Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate

1 Market Scope

1.1 Product Details and Introduction

1.1.1 Diagnostic Radiopharmaceuticals -Product Introduction and Major Manufacturers

1.1.2 Therapy Radiopharmaceuticals -Product Introduction and Major Manufacturers

1.1.3 Enriched Stable Isotopes -Product Introduction and Major Manufacturers

1.2 Market Snapshot

1.2.1 Major Companies Overview

1.2.2 Market Concentration

1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Regional Market

2.1 Regional Market Share in Terms of Production (2019-2026)

2.2 Regional Market Share in Terms of Revenue (2019-2026)

2.3 Regional Market Share in Terms of Consumption (2019-2026)

3 Global Radiopharmaceuticals in Nuclear Medicine Market Assessment by Type

3.1 Global Radiopharmaceuticals in Nuclear Medicine Production by Type (2015-2026)

3.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue by Type (2015-2026)

3.3 North America Radiopharmaceuticals in Nuclear Medicine Production and Revenue by Type (2015-2026)

3.4 Asia Radiopharmaceuticals in Nuclear Medicine Production and Revenue by Type (2015-2026)

3.5 Europe Radiopharmaceuticals in Nuclear Medicine Production and Revenue by Type (2015-2026)

3.6 Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Production and Revenue by Type (2015-2026)

3.7 South America Radiopharmaceuticals in Nuclear Medicine Production and Revenue by Type (2015-2026)



4 Global Radiopharmaceuticals in Nuclear Medicine Market Assessment by Application

4.1 Historical & Forecast Global Radiopharmaceuticals in Nuclear Medicine Consumption, Different Application Field (2015-2026)

4.2 Historical & Forecast North America Radiopharmaceuticals in Nuclear Medicine Consumption, Different Application Field (2015-2026)

4.3 Historical & Forecast Asia Radiopharmaceuticals in Nuclear Medicine Consumption, Different Application Field (2015-2026)

4.4 Historical & Forecast Europe Radiopharmaceuticals in Nuclear Medicine Consumption, Different Application Field (2015-2026)

4.5 Historical & Forecast Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption, Different Application Field (2015-2026)

4.6 Historical & Forecast South America Radiopharmaceuticals in Nuclear Medicine Consumption, Different Application Field (2015-2026)



5 North America

5.1 US Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

5.2 Canada Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

5.3 Mexico Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6 Asia

6.1 China Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.2 Japan Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.3 India Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.4 Korea Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

6.5 Southeat Asia Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7 Europe

7.1 Germany Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.2 UK Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.3 France Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.4 Russia Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

7.5 Italy Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8 Middle East and Africa

8.1 Saudi Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.2 UAE Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.3 Egypt Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.4 Nigeria Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

8.5 South Africa Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9 South America

9.1 Brazil Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9.2 Argentina Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

9.3 Colombia Radiopharmaceuticals in Nuclear Medicine Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)

10 Global Radiopharmaceuticals in Nuclear Medicine Average Price Trend

10.1 Market Price for Each Type of Radiopharmaceuticals in Nuclear Medicine in North America (2015-2026)

10.2 Market Price for Each Type of Radiopharmaceuticals in Nuclear Medicine in Asia (2015-2026)

10.3 Market Price for Each Type of Radiopharmaceuticals in Nuclear Medicine in Europe (2015-2026)

10.4 Market Price for Each Type of Radiopharmaceuticals in Nuclear Medicine in Middle East & Africa (2015-2026)

10.5 Market Price for Each Type of Radiopharmaceuticals in Nuclear Medicine in South America (2015-2026)



11 Value Chain (Impact of COVID-19)

11.1 Radiopharmaceuticals in Nuclear Medicine Value Chain Analysis

11.1.1 Upstream

11.1.2 Downstream

11.2 COVID-19 Impact on Radiopharmaceuticals in Nuclear Medicine Industry

11.2.1 Industrial Policy Issued Under the Epidemic Situation

11.3 Cost-Under the Epidemic Situation

11.3.1 Cost of Raw Material

11.4 Channel Analysis

11.4.1 Distribution Channel-Under the Epidemic Situation

11.4.2 Distributors



12 Radiopharmaceuticals in Nuclear Medicine Competitive Analysis

12.1 Bracco Imaging S.P.A.

12.1.1 Bracco Imaging S.P.A. Company Profiles

12.1.2 Bracco Imaging S.P.A. Product Introduction

12.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.1.4 SWOT Analysis

12.2 Cambridge Isotope Laboratories, Inc.

12.2.1 Cambridge Isotope Laboratories, Inc. Company Profiles

12.2.2 Cambridge Isotope Laboratories, Inc. Product Introduction

12.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.2.4 SWOT Analysis

12.3 Cardinal Health, Inc.

12.3.1 Cardinal Health, Inc. Company Profiles

12.3.2 Cardinal Health, Inc. Product Introduction

12.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.3.4 SWOT Analysis

12.4 Covidien, Plc

12.4.1 Covidien, Plc Company Profiles

12.4.2 Covidien, Plc Product Introduction

12.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.4.4 SWOT Analysis

12.5 Isotec, Inc. (Sigma-Aldrich)

12.5.1 Eczacibasi-Monrol Company Profiles

12.5.2 Eczacibasi-Monrol Product Introduction

12.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.5.4 SWOT Analysis

12.6 Fujifilm Holdings Corporation

12.6.1 Fujifilm Holdings Corporation Company Profiles

12.6.2 Fujifilm Holdings Corporation Product Introduction

12.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.6.4 SWOT Analysis

12.7 GE Healthcare (Subsidiary Of General Electric Company)

12.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Profiles

12.7.2 GE Healthcare (Subsidiary Of General Electric Company) Product Introduction

12.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.7.4 SWOT Analysis

12.8 IBA Group

12.8.1 IBA Group Company Profiles

12.8.2 IBA Group Product Introduction

12.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.8.4 SWOT Analysis

12.9 Isotec, Inc. (Sigma-Aldrich)

12.9.1 Isotec, Inc. (Sigma-Aldrich) Company Profiles

12.9.2 Isotec, Inc. (Sigma-Aldrich) Product Introduction

12.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.9.4 SWOT Analysis

12.10 Lantheus Medical Imaging, Inc.

12.10.1 Lantheus Medical Imaging, Inc. Company Profiles

12.10.2 Lantheus Medical Imaging, Inc. Product Introduction

12.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Production, Revenue (2015-2020)

12.10.4 SWOT Analysis

12.11 Nordion, Inc.

12.12 Ntp Radioisotopes (Pty), Ltd.

12.13 Siemens Healthcare (Subsidiary Of Siemens AG)

12.14 Taiyo Nippon Sanso Corporation

12.15 Urenco Limited

12.16 Rotem Industries, Ltd., Inc.

12.17 Australian Nuclear Association And Technology Organization (ANSTO)

12.18 Board of Radiation And Isotope Technology (BRIT)

12.19 Institute of Atomic Energy Polatom Radioisotope Centre

12.20 Institute of Isotopes Co., Ltd.

12.21 Institute Of Radioelement (IRE)

13 Conclusion

List of Figure

List of Tables and Figures



Figure Product Introduction

Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)

Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share of Top 5 Players

Table CAGR of Major Market (2021-2026)

Table CAGR in Terms of Production of Each Type (2015-2026)

Table Regional Market Share in Terms of Production (2019-2026)

Figure Regional Market Share in Terms of Production (2019 - 2020)

Table Regional Market Share in Terms of Revenue (2019-2026)

Figure Regional Market Share in Terms of Revenue (2019 - 2020)

Figure Regional Market Share in Terms of Consumption (2019 - 2020)

Figure Regional Market Share in Terms of Consumption (2019 - 2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Production (K Unit) by Type (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Production (K Unit) and Growth Rate (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Production Market Share (%) by Type (2019 -2020)

Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2026)

Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) by Type (2019-2020)

Figure North America Radiopharmaceuticals in Nuclear Medicine Production (K Unit) by Type (2015-2026)

Figure North America Radiopharmaceuticals in Nuclear Medicine Production (K Unit) and Growth Rate (2015-2026)

Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2015-2026)

Figure North America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2026)

Figure Asia Radiopharmaceuticals in Nuclear Medicine Production (K Unit) by Type (2015-2026)

Figure Asia Radiopharmaceuticals in Nuclear Medicine Production (K Unit) and Growth Rate (2015-2026)

Figure Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2015-2026)

Figure Asia Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2026)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Production (K Unit) by Type (2015-2026)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Production (K Unit) and Growth Rate (2015-2026)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2015-2026)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2026)

Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Production (K Unit) by Type (2015-2026)

Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Production (K Unit) and Growth Rate (2015-2026)

Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2015-2026)

Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2026)

Figure South America Radiopharmaceuticals in Nuclear Medicine Production (K Unit) by Type (2015-2026)

Figure South America Radiopharmaceuticals in Nuclear Medicine Production (K Unit) and Growth Rate (2015-2026)

Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Type (2015-2026)

Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2015-2026)

Table Historical & Forecast Radiopharmaceuticals in Nuclear Medicine Different Application Field Consumption (K Unit)

Figure Consumption (K Unit) and Growth Rate (2015-2026)

Figure Different Application Field Consumption Market Share (%) (2019-2020)

Table Historical & Forecast Radiopharmaceuticals in Nuclear Medicine Different Application Field Consumption (K Unit)

Figure North America Radiopharmaceuticals in Nuclear Medicine Consumption (K Unit) and Growth Rate (2015-2026)

Figure North America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Radiopharmaceuticals in Nuclear Medicine Different Application Field Consumption (K Unit)

Figure Asia Radiopharmaceuticals in Nuclear Medicine Consumption (K Unit) and Growth Rate (2015-2026)

Figure Asia Radiopharmaceuticals in Nuclear Medicine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Radiopharmaceuticals in Nuclear Medicine Different Application Field Consumption (K Unit)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption (K Unit) and Growth Rate (2015-2026)

Figure Europe Radiopharmaceuticals in Nuclear Medicine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Radiopharmaceuticals in Nuclear Medicine Different Application Field Consumption (K Unit)

Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption (K Unit) and Growth Rate (2015-2026)

Figure Middle East & Africa Radiopharmaceuticals in Nuclear Medicine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Radiopharmaceuticals in Nuclear Medicine Different Application Field Consumption (K Unit)

Figure South America Radiopharmaceuticals in Nuclear Medicine Consumption (K Unit) and Growth Rate (2015-2026)

Figure South America Radiopharmaceuticals in Nuclear Medicine Consumption Market Share (%) by Application (2015-2026)

Table Historical & Forecast Radiopharmaceuticals in Nuclear Medicine Different Application Field Consumption (K Unit)

Table US Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Canada Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Mexico Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table China Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Japan Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table India Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Korea Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Germany Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table UK Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table France Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Russia Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Italy Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Saudi Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table UAE Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Egypt Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Nigeria Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table South Africa Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Brazil Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Argentina Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Colombia Radiopharmaceuticals in Nuclear Medicine Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold

Figure Proportion of Products Sold (%) (2015 -2026)

Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Nuclear Medicine in China

Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Nuclear Medicine in EU

Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Nuclear Medicine in USA

Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Nuclear Medicine in Japan

Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Nuclear Medicine in India

Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Nuclear Medicine in Southeast Asia

Table Market Price (USD/Unit) for Each Type of Radiopharmaceuticals in Nuclear Medicine in South America

Figure Value Chain Structure of Radiopharmaceuticals in Nuclear Medicine

Table Value Chain

Table Key Suppliers of Raw Material/Components

Table Key Downstream Customer in Each Application Field

Table Industry News List of Radiopharmaceuticals in Nuclear Medicine

Figure Cost Structure of Radiopharmaceuticals in Nuclear Medicine in 2020

Table Distributors/Traders List

Table Bracco Imaging S.P.A. Profiles

Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Bracco Imaging S.P.A. SWOT Analysis

Table Cambridge Isotope Laboratories, Inc. Profiles

Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Cambridge Isotope Laboratories, Inc. SWOT Analysis

Table Cardinal Health, Inc. Profiles

Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Cardinal Health, Inc. SWOT Analysis

Table Covidien, Plc Profiles

Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Covidien, Plc SWOT Analysis

Table Eczacibasi-Monrol Profiles

Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Eczacibasi-Monrol Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Eczacibasi-Monrol SWOT Analysis

Table Fujifilm Holdings Corporation Profiles

Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Fujifilm Holdings Corporation SWOT Analysis

Table GE Healthcare (Subsidiary Of General Electric Company) Profiles

Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure GE Healthcare (Subsidiary Of General Electric Company) SWOT Analysis

Table IBA Group Profiles

Table IBA Group Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure IBA Group SWOT Analysis

Table Isotec, Inc. (Sigma-Aldrich) Profiles

Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Isotec, Inc. (Sigma-Aldrich) SWOT Analysis

Table Lantheus Medical Imaging, Inc. Profiles

Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Lantheus Medical Imaging, Inc. SWOT Analysis

Table Nordion, Inc. Profiles

Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Nordion, Inc. SWOT Analysis

Table Ntp Radioisotopes (Pty), Ltd. Profiles

Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Ntp Radioisotopes (Pty), Ltd. SWOT Analysis

Table Siemens Healthcare (Subsidiary Of Siemens AG) Profiles

Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Siemens Healthcare (Subsidiary Of Siemens AG) SWOT Analysis

Table Taiyo Nippon Sanso Corporation Profiles

Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Taiyo Nippon Sanso Corporation SWOT Analysis

Table Urenco Limited Profiles

Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Urenco Limited Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Urenco Limited SWOT Analysis

Table Rotem Industries, Ltd., Inc. Profiles

Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Rotem Industries, Ltd., Inc. SWOT Analysis

Table Australian Nuclear Association And Technology Organization (ANSTO) Profiles

Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Australian Nuclear Association And Technology Organization (ANSTO) SWOT Analysis

Table Board of Radiation And Isotope Technology (BRIT) Profiles

Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Board of Radiation And Isotope Technology (BRIT) SWOT Analysis

Table Institute of Atomic Energy Polatom Radioisotope Centre Profiles

Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Institute of Atomic Energy Polatom Radioisotope Centre SWOT Analysis

Table Institute of Isotopes Co., Ltd. Profiles

Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Figure Institute of Isotopes Co., Ltd. SWOT Analysis

Table Institute Of Radioelement (IRE) Profiles

Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Product Introduction

Figure Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)